Results 21 to 30 of about 256,729 (300)

Molecular confirmation of Sarcocystis fayeri in a donkey [PDF]

open access: yes, 2017
Sarcocystis fayeri is a canine protozoan parasite with an equine intermediate host. Historically classified as an incidental pathogen, recent literature has described the toxic effects of Sarcocystis fayeri in human food poisoning, and highlighted ...
Coultous, Robert M.   +4 more
core   +1 more source

Transgenic and physiological mouse models give insights into different aspects of amyotrophic lateral sclerosis

open access: yesDisease Models & Mechanisms, 2019
A wide range of genetic mouse models is available to help researchers dissect human disease mechanisms. Each type of model has its own distinctive characteristics arising from the nature of the introduced mutation, as well as from the specific changes to
Francesca De Giorgio   +3 more
doaj   +1 more source

Validation of the Short Physical Performance Battery via Plantar Pressure Analysis Using Commercial Smart Insoles

open access: yesSensors, 2023
This cross-sectional study, conducted at a tertiary care hospital’s rehabilitation clinic, aimed to validate Short Physical Performance Battery (SPPB) results obtained through plantar pressure analysis using commercial smart insoles (SPPB-SI) and to ...
Chan Woong Jang   +4 more
doaj   +1 more source

The TREAT-NMD advisory committee for therapeutics (TACT): an innovative de-risking model to foster orphan drug development [PDF]

open access: yes, 2015
Despite multiple publications on potential therapies for neuromuscular diseases (NMD) in cell and animal models only a handful reach clinical trials. The ability to prioritise drug development according to objective criteria is particularly critical in ...
Allen, Hugh   +49 more
core   +4 more sources

Treatment algorithm for infants diagnosed with spinal muscular atrophy through newborn screening [PDF]

open access: yes, 2018
Spinal muscular atrophy (SMA) is an autosomal recessive disease characterized by the degeneration of alpha motor neurons in the spinal cord, leading to muscular atrophy.
Connolly, Anne   +14 more
core   +2 more sources

Daratumumab–bortezomib–dexamethasone use in relapsed POEMS syndrome

open access: yeseJHaem, 2022
POEMS syndrome is a rareparaneoplastic disorder driven by an underlying low level plasma cell dyscrasiaand associated with elevated serum vascular endothelial growth factor (VEGF).
Jahanzaib Khwaja   +5 more
doaj   +1 more source

Anthropometry of arm: nutritional risk indicator in amyotrophic lateral sclerosis

open access: yesNeurology International, 2015
The aim of the paper is to examine the correlation between clinical data, nutritional, respiratory and functional parameters in amyotrophic lateral sclerosis (ALS). This is a descriptive study of 111 ALS patients [91 spinal onset (GS) and 20 bulbar onset
Cristina Cleide dos Santos Salvioni   +3 more
doaj   +1 more source

A fresh look at paralytics in the critically ill: real promise and real concern. [PDF]

open access: yes, 2012
Neuromuscular blocking agents (NMBAs), or "paralytics," often are deployed in the sickest patients in the intensive care unit (ICU) when usual care fails.
Kenyon, Nicholas J   +2 more
core   +2 more sources

Split hand phenomenon: An early marker for amyotrophic lateral sclerosis

open access: yesRevista Mexicana de Neurociencia, 2021
Background: Amyotrophic lateral sclerosis (ALS) is a progressive disease characterized by degeneration of upper and lower motor neurons. Time from symptom onset to confirmed diagnosis has been reported from 8 to 15 months in ALS.
Javier A. Galnares-Olalde   +4 more
doaj   +1 more source

Immunological Targets in Generalized Myasthenia Gravis Treatment: Where Are We Going Now?

open access: yesBrain Sciences
Background: Generalized myasthenia gravis (gMG) is a heterogeneous autoimmune disorder marked by antibody-mediated disruption of neuromuscular transmission.
Elena Rossini   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy